UROwebinar: Biomarkers and precision medicine in prostate cancer management
This UROwebinar, organised by the European School of Urology and the EAU Section of Oncological Urology, will explore the role of the implementation of biomarkers and precision medicine in the therapeutic algorithm of localised, advanced, and metastatic prostate cancer.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | To be approved |
| Location | Online |
Key opinion leaders will discuss how to apply biomarkers in clinical decision-making, guide treatment intensity, and evaluate the impact of precision strategies on patient outcomes. The UROwebinar aims to demonstrate how these tools can help personalise care, reduce overtreatment, and improve survival. The experts will also discuss how to implement novel biomarkers and precision medicine in routine practice.
Faculty
Dr. G. Gandaglia (IT)
Moderator
Mr. D.E. Spratt (US)
Speaker
A. Bernard-Tessier (FR)
Speaker
Acknowledgement
Acknowledgement
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.